Impact of Prior Therapy for Diabetic Macular Edema (DME) on Visual and Anatomic Outcomes Following Treatment with Intravitreal Aflibercept: Results from the Phase 3 VISTA-DME and VIVID-DME Studies

被引：0
|
作者：
Quan Dong Nguyen [1 ]
机构：
[1] Univ Nebraska Med Ctr, Stanley M Truhlsen Eye Inst, Omaha, NE USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
499 diabetic retinopathy; 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5055
引用
收藏
页数：2
相关论文
共 41 条
  • [1] INTRAVITREAL AFLIBERCEPT FOR THE TREATMENT OF DIABETIC MACULAR EDEMA (DME): FINDINGS FROM THE VIVID-DME AND VISTA-DME CLINICAL TRIALS
    Midena, E.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (03) : 459 - 459
  • [2] Evaluation of Intravitreal Aflibercept for Treatment of Diabetic Macular Edema: Visual Acuity Subgroups in VIVID-DME and VISTA-DME
    Lorenz, Katrin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] Intravitreal Aflibercept (IVT-AFL) for Diabetic Macular Edema (DME): 3 Year Data from VIVID-DME and VISTA-DME
    Staurenghi, G.
    Metzig, C.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [4] Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies
    Mitchell, Paul
    McAllister, Ian
    Larsen, Michael
    Staurenghi, Giovanni
    Korobelnik, Jean-Francois
    Boyer, David S.
    Do, Diana, V
    Brown, David M.
    Katz, Todd A.
    Berliner, Alyson
    Vitti, Robert
    Zeitz, Oliver
    Metzig, Carola
    Lu, Chengxing
    Holz, Frank G.
    OPHTHALMOLOGY RETINA, 2018, 2 (10): : 988 - 996
  • [5] Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: A review of VIVID-DME and VISTA-DME data
    Ziemssen F.
    Schlottman P.G.
    Lim J.I.
    Agostini H.
    Lang G.E.
    Bandello F.
    International Journal of Retina and Vitreous, 2 (1)
  • [6] Impact of Intravitreal Aflibercept (IVT-AFL) on Diabetic Retinopathy in the VIVID-DME and VISTA-DME Studies
    Larsen, L. M.
    Metzig, C.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [7] Rapid Response to Intravitreal Aflibercept (IVT-AFL) in Patients with Diabetic Macular Edema (DME) in the Vivid-dme and Vista-DME Trials
    Varano, Monica
    Korobelnik, Jean-Francois
    Parravano, Mariacristina
    Katz, Todd A.
    Metzig, Carola
    OPHTHALMOLOGICA, 2014, 232 : 22 - 22
  • [8] Intravitreal Aflibercept Injection (IAI) for Diabetic Macular Edema (DME): Primary and Additional Endpoint Results from the 12-Month Phase 3 VISTA-DME and VIVID-DME Studies
    Brown, David M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [9] Rescue Therapy Use in Patients with Diabetic Macular Edema (DME) Receiving Intravitreal Aflibercept (IVT-AFL) or Laser: Results from the VIVID-DME and VISTA-DME Trials
    Rehak, Matus
    Korobelnik, Jean-Francois
    Metzig, Carola
    OPHTHALMOLOGICA, 2014, 232 : 17 - 18
  • [10] TIME COURSE OF VISUAL ACUITY CHANGES WITH INTRAVITREAL AFLIBERCEPT (IVT-AFL) OR MACULAR LASER PHOTOCOAGULATION IN PATIENTS WITH DIABETIC MACULAR EDEMA (DME): OUTCOMES FROM THE VIVID-DME AND VISTA-DME CLINICAL TRIALS
    McAllister, Ian
    Holz, Frank
    Metzig, Carola
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 13 - 13
12345